Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 14, Pages 3504
Publisher
MDPI AG
Online
2019-07-17
DOI
10.3390/ijms20143504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome
- (2015) Merle Fernandes et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- ZINC 15 – Ligand Discovery for Everyone
- (2015) Teague Sterling et al. Journal of Chemical Information and Modeling
- BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers
- (2015) Z. Tang et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of quorum sensing and biofilm formation in Vibrio harveyi by 4-fluoro-DPD; a novel potent inhibitor of AI-2 signalling
- (2014) Manikandan Kadirvel et al. CHEMICAL COMMUNICATIONS
- Preliminary results of a novel quorum sensing inhibitor against pneumococcal infection and biofilm formation with special interest to otitis media and cochlear implantation
- (2014) Raşit Cevizci et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- The Antitumor Activity of Meisoindigo against Human Colorectal Cancer HT-29 CellsIn VitroandIn Vivo
- (2014) Zuo Mingxin et al. JOURNAL OF CHEMOTHERAPY
- Aspirin is an efficient inhibitor of quorum sensing, virulence and toxins in Pseudomonas aeruginosa
- (2014) Somaia A. El-Mowafy et al. MICROBIAL PATHOGENESIS
- Identification of Anti-virulence Compounds That Disrupt Quorum-Sensing Regulated Acute and Persistent Pathogenicity
- (2014) Melissa Starkey et al. PLoS Pathogens
- Antivirulence activity of azithromycin in Pseudomonas aeruginosa
- (2014) Francesco Imperi et al. Frontiers in Microbiology
- Structure of type II dehydroquinase fromPseudomonas aeruginosa
- (2014) Scott Reiling et al. Acta Crystallographica Section F-Structural Biology Communications
- Synthesis of (R)-norbgugaine and its potential as quorum sensing inhibitor against Pseudomonas aeruginosa
- (2013) Mahesh S. Majik et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
- (2013) C. T. O'Loughlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Native Agonist and Synthetic Inhibitor Recognition by the Pseudomonas aeruginosa Quorum Sensing Regulator PqsR (MvfR)
- (2013) Aravindan Ilangovan et al. PLoS Pathogens
- Food as a Source for Quorum Sensing Inhibitors: Iberin from Horseradish Revealed as a Quorum Sensing Inhibitor of Pseudomonas aeruginosa
- (2012) Tim Holm Jakobsen et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence
- (2012) Shannan J. Ho Sui et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A new quorum-sensing inhibitor attenuates virulence and decreases antibiotic resistance in Pseudomonas aeruginosa
- (2012) Yu-Xiang Yang et al. JOURNAL OF MICROBIOLOGY
- Race against time to develop new antibiotics
- (2011) . . BULLETIN OF THE WORLD HEALTH ORGANIZATION
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors
- (2009) Li Xie et al. PLoS Computational Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started